Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"

E L Fosbøl; G H Gislason; L Køber; C Torp-Pedersen

doi:10.1038/clpt.2009.204

Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"

E L Fosbøl, G H Gislason, L Køber, C Torp-Pedersen

Originalsprog	Engelsk
Tidsskrift	Clinical Pharmacology and Therapeutics
Vol/bind	86
Udgave nummer	6
Sider (fra-til)	602-604
Antal sider	3
ISSN	0009-9236
DOI	https://doi.org/10.1038/clpt.2009.204
Status	Udgivet - dec. 2009

Adgang til dokumentet

10.1038/clpt.2009.204

Citationsformater

Fosbøl, E. L., Gislason, G. H., Køber, L., & Torp-Pedersen, C. (2009). Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". Clinical Pharmacology and Therapeutics, 86(6), 602-604. https://doi.org/10.1038/clpt.2009.204

Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". / Fosbøl, E L ; Gislason, G H ; Køber, L et al.
I: Clinical Pharmacology and Therapeutics, Bind 86, Nr. 6, 12.2009, s. 602-604.

Publikation: Bidrag til tidsskrift › Letter › peer review

Fosbøl, EL , Gislason, GH , Køber, L & Torp-Pedersen, C 2009, 'Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"', Clinical Pharmacology and Therapeutics, bind 86, nr. 6, s. 602-604. https://doi.org/10.1038/clpt.2009.204

Fosbøl EL , Gislason GH , Køber L , Torp-Pedersen C. Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". Clinical Pharmacology and Therapeutics. 2009 dec.;86(6):602-604. doi: 10.1038/clpt.2009.204

Fosbøl, E L ; Gislason, G H ; Køber, L et al. / Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". I: Clinical Pharmacology and Therapeutics. 2009 ; Bind 86, Nr. 6. s. 602-604.

@article{9f7274dc9e504c10825046ae5a5ecdd4,

title = "Response to {"}No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs,{"} {"}Do NSAIDs Actually Protect Against Myocardial Infarction and Death?,{"} and {"}Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?{"}",

author = "Fosb{\o}l, {E L} and Gislason, {G H} and L K{\o}ber and C Torp-Pedersen",

year = "2009",

month = dec,

doi = "10.1038/clpt.2009.204",

language = "English",

volume = "86",

pages = "602--604",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"

AU - Fosbøl, E L

AU - Gislason, G H

AU - Køber, L

AU - Torp-Pedersen, C

PY - 2009/12

Y1 - 2009/12

U2 - 10.1038/clpt.2009.204

DO - 10.1038/clpt.2009.204

M3 - Letter

C2 - 28547832

SN - 0009-9236

VL - 86

SP - 602

EP - 604

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 6

ER -